Holland C Detke

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Top Venues

Journal of medical economics

Advances in therapy

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Richard B Lipton, Dawn C Buse, Claire H Sandoe, Janet H Ford, Austin L Hand, Jakub P Jedynak, Martha D Port, Holland C Detke
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study. Headache (2023)
E Anne MacGregor, Rose Okonkwo, Holland C Detke, Pepa Polavieja, Maria S Fernandes, Jelena M Pavlovic
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE-1 and EVOLVE-2. Headache (2023)
Patricia Pozo-Rosich, Holland C Detke, Shufang Wang, David Doležil, Lily Q Li, Sheena K Aurora, Uwe Reuter
Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study. Current medical research and opinion 38 (5) (2022)
Joshua A Tobin, Shivang Joshi, Janet H Ford, Russell M Nichols, Shonda A Foster, Dustin Ruff, Holland C Detke, Sheena K Aurora
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN). Journal of medical economics 25 (1) (2022)
Uwe Reuter, Christian Lucas, David Dolezil, Austin L Hand, Martha D Port, Russell M Nichols, Chad Stroud, Antje Tockhorn-Heidenreich, Holland C Detke
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial. Advances in therapy 38 (11) (2021)